ROCKVILLE, Md, Sept. 26-When times get tough, the tough get two jobs, which is the case with Andrew C. von Eschenbach, M.D., who is stepping in as acting head of the Food and Drug Administration, while still holding the reins at the National Cancer Institute.
Within hours of Friday's abrupt resignation of FDA commissioner Lester Crawford, D.V.M., the White House tapped Dr. von Eschenbach, who said at a press conference that he plans to be 100% committed to both jobs.
"100% committed to both jobs." Talk about setting himself up for a fall! This is impossible and already Dr Eschenbach has revealed his lack of media savvy.
Imagine a drug rep announcing that they were planning to "double dip" and work for both GSK and Pfizer at the same time. But they were 100% committed to both jobs.
What about conflicts of interest? Is Dr E going to draw both the NCI and FDA salaries?
http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/tb/1804
Looks like Insider is not the only one with questions:
http://abcnews.go.com/Politics/wireStory?id=1164100&CMP=OTC-RSSFeeds0312
No comments:
Post a Comment